The focus of Sartorius' third Research Xchange Forum (RXF2019) on April 25, 2019 will be on Car-T cell therapy. By organizing this event, the company intends to promote interdisciplinary exchange and foster potential collaborations between academia and industry on highly promising scientific fields relevant to both scientists and businesses.
Sartorius is hosting its third Research Xchange Forum (RXF2019) on April 25, 2019, which will spotlight Car-T cell therapy.
(Source: Sartorius)
Göttingen/Germany — The forum is organized in collaboration with Science/AAAS. The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society, and the forum will be held at the AAAS headquarters in Washington DC. Experts from the academic, clinical and biotech sectors will offer insights on novel developments in CAR-T cell therapies.
Guest speakers will include Prof. Bruce Levine (University of Pennsylvania), Rick Morgan, Sr. VP Immunogenetics (Editas Medicine), and others from institutions such as UCLA, Boston University, MD Anderson Cancer Center, Horizon Discovery, Colorado State University, Masthercell and St. Jude Children's Research Hospital.
The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy will be awarded in an invitation only post-event ceremony. Through sponsoring the award, Sartorius and Science/AAAS aim to recognize outstanding research contributions made in the regenerative medicine and cell therapy fields by the next generation of young scientists, the next thought leaders shaping our future as a society.
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.